Scientific Advisory Board Fireside Chat: Aligning on Future Analytical Standards to Reduce Risk & Improve Decision Making Across Cell & Gene Therapy
9:00 am - Wednesday 2nd December 2026
Meet the Scientific Advisory Board whose expertise has helped shape a highly relevant, industry focused agenda for this year’s meeting.
They will be exploring topics such as:
- Defining priorities that shift analytical development from support function to core risk management
- Identifying where challenges are similar and different across modalities and what that means for teams
- Clarifying practical gaps that still limit progress across analytical development and QC
Speakers:
Executive Director, Analytical Strategy, Cell Therapy Global Quality
Bristol Myers Squibb